Your browser doesn't support javascript.
loading
Epidermal Growth Factor Receptor-Targeting Peptide Nanoparticles Simultaneously Deliver Gemcitabine and Olaparib To Treat Pancreatic Cancer with Breast Cancer 2 ( BRCA2) Mutation.
Du, Chong; Qi, Yingqiu; Zhang, Yinlong; Wang, Yazhou; Zhao, Xiao; Min, Huan; Han, Xuexiang; Lang, Jiayan; Qin, Hao; Shi, Quanwei; Zhang, Zhengkui; Tian, Xiaodong; Anderson, Greg J; Zhao, Ying; Nie, Guangjun; Yang, Yinmo.
Afiliação
  • Du C; Department of General Surgery , Peking University First Hospital , Beijing 100034 , China.
  • Qi Y; CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety , National Center for Nanoscience and Technology , Beijing 100190 , China.
  • Zhang Y; CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety , National Center for Nanoscience and Technology , Beijing 100190 , China.
  • Wang Y; College of Science , Northeastern University , Shenyang 110819 , China.
  • Zhao X; CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety , National Center for Nanoscience and Technology , Beijing 100190 , China.
  • Min H; College of Pharmaceutical Science , Jilin University , Changchun 130021 , China.
  • Han X; Department of General Surgery , Peking University First Hospital , Beijing 100034 , China.
  • Lang J; CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety , National Center for Nanoscience and Technology , Beijing 100190 , China.
  • Qin H; CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety , National Center for Nanoscience and Technology , Beijing 100190 , China.
  • Shi Q; CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety , National Center for Nanoscience and Technology , Beijing 100190 , China.
  • Zhang Z; College of Science , Northeastern University , Shenyang 110819 , China.
  • Tian X; CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety , National Center for Nanoscience and Technology , Beijing 100190 , China.
  • Anderson GJ; University of Chinese Academy of Sciences , Beijing 100049 , China.
  • Zhao Y; CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety , National Center for Nanoscience and Technology , Beijing 100190 , China.
  • Nie G; University of Chinese Academy of Sciences , Beijing 100049 , China.
  • Yang Y; CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety , National Center for Nanoscience and Technology , Beijing 100190 , China.
ACS Nano ; 12(11): 10785-10796, 2018 11 27.
Article em En | MEDLINE | ID: mdl-30407790
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Ftalazinas / Piperazinas / Sistemas de Liberação de Medicamentos / Proteína BRCA2 / Desoxicitidina / Nanopartículas Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: ACS Nano Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Ftalazinas / Piperazinas / Sistemas de Liberação de Medicamentos / Proteína BRCA2 / Desoxicitidina / Nanopartículas Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: ACS Nano Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos